Top compounds associated with response to KTI12


Feature Type Standardized
Nominal ANOVA
mRNA NPC-26 CTRPv2 pan-cancer AAC 0.13 0.002
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.12 0.002
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC 0.34 0.002
mRNA lovastatin CTRPv2 pan-cancer AAC 0.12 0.002
mRNA MST-312 CTRPv2 pan-cancer AAC 0.11 0.002
mRNA Docetaxel gCSI pan-cancer AAC 0.16 0.003
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.1 0.003
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.11 0.004
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.099 0.005
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.005
Download CSV